Anti-atherogenic effect of insulin in vivo

Journal of Vascular Research

Volumn 42, Issue 6, 2005, Pages 455-462

  Kim, Tony ^a   Chan, Kalam K ^a   Dhaliwall, Jiwanjeet K ^a   Huynh, Nghia ^a   Suen, Renee ^a   Uchino, Hiroshi ^a   Naigamwalla, Dinaz ^a   Bendeck, Michelle P ^a   Giacca, Adria ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Hyperinsulinemia; Hyperlipidemia; Insulin resistance syndrome; Restenosis; Vascular smooth muscle cell

Indexed keywords

INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; ATHEROGENESIS; CAROTID ARTERY; CELL GROWTH; CONTROLLED STUDY; HYPERINSULINEMIA; HYPERLIPIDEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ATHEROSCLEROSIS; BALLOON DILATATION; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL DIVISION; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; HYPERINSULINISM; HYPERLIPIDEMIAS; INSULIN; MALE; RATS; RATS, SPRAGUE-DAWLEY; TUNICA INTIMA;

EID: 27344455048     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088099     Document Type: Article

References (36)

1. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, National Heart, Lung, and Blood Institute, American Heart Association: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-438.
2. Engelgau MM, Geiss LS, Saaddine JB, Boyle JP, Benjamin SM, Gregg EW, Tierney EF, Rios-Burrows N, Mokdad AH, Ford ES, Imperatore G, Narayan KM: The evolving diabetes burden in the United States. Ann Intern Med 2004;140:945-950.
3. Ford ES: The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004;173:309-314.
4. Moussa I, Leon MB, Baim DS, O'Neill WW, Popma JJ, Buchbinder M, Midwall J, Simonton CA, Keim E, Wang P, Kuntz RE, Moses JW: Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 2004;109:2273-2278.
5. Takagi T, Yoshida K, Akasaka T, Kaji S, Kawamoto T, Honda Y, Yamamuro A, Hozumi T, Morioka S: Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients: a serial intravascular ultrasound study. J Am Coll Cardiol 2000;36:731-738.
6. Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA, Hong MK, Popma JJ, Leon MB: Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation 1997;95:1366-1369.
7. Yang CM, Chien CS, Hsiao LD, Pan SL, Wang CC, Chiu CT, Lin CC: Mitogenic effect of oxidized low-density lipoprotein on vascular smooth muscle cells mediated by activation of Ras/Raf/MEK/MAPK pathway. Br J Pharmacol 2001;132:1531-1541.
8. Klouche M, Rose-John S, Schmiedt W, Bhakdi S: Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation. Circulation 2000;101:1799-1805.
9. Lu G, Greene EL, Nagai T, Egan BM: Reactive oxygen species are critical in the oleic acid-mediated mitogenic signaling pathway in vascular smooth muscle cells. Hypertension 1998;32:1003-1010.
10. Li Y, Lu W, Bu G: Essential role of the low density lipoprotein receptor-related protein in vascular smooth muscle cell migration. FEBS Lett 2003;555:346-350.
11. Ruige JB, Assendelft WJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM: Insulin and risk of cardiovascular disease: a meta-analysis. Circulation 1998;97:996-1001.
12. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R: Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996;93:1809-1817.
13. Xi XP, Graf K, Goetze S, Hsueh WA, Law RE: Inhibition of MAP kinase blocks insulin-mediated DNA synthesis and transcriptional activation of c-fos by Elk-1 in vascular smooth muscle cells. FEBS Lett 1997;417:283-286.
14. Wang CC, Gurevich I, Draznin B: Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways. Diabetes 2003;52:2562-2569.
15. Zeng G, Nystrom FH, Ravichandran LV, Cong LN, Kirby M, Mostowski H, Quon MJ: Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000;101:1539-1545.
16. Sarkar R, Gordon D, Stanley JC, Webb RC: Dual cell cycle-specific mechanisms mediate the antimitogenic effects of nitric oxide in vascular smooth muscle cells. J Hypertens 1997;15:275-283.
17. Kahn AM, Allen JC, Seidel CL, Zhang S: Insulin inhibits migration of vascular smooth muscle cells with inducible nitric oxide synthase. Hypertension 2000;35:303-306.
18. Jiang ZY, Lin YW, Clemont A, Feener EP, Hein KD, Igarashi M, Yamauchi T, White MF, King GL: Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 1999;104:447-457.
19. Akishita M, Ouchi Y, Miyoshi H, Kozaki K, Inoue S, Ishikawa M, Eto M, Toba K, Orimo H: Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: effects on migration and proliferation of vascular smooth muscle cells. Atherosclerosis 1997;130:1-10.
20. Wang PY: The reliability of a compressed mixture of insulin and palmitic acid to sustain a reduction in hyperglycemia in rodents. ASAIO Trans 1987;33:319-322.
21. Whitley E, Ball J: Statistics review 4: sample size calculations. Crit Care 2002;6:335-341.
22. Wright GL, Morrison R, Fultz ME, Wright G, Mccumbee W, Wehner P, Studeny M: Effect of fasting on vascular contractility in lean and obese Zucker rats. Clin Nutr 2003;22:359-363.
23. Goetze S, Blaschke F, Stawowy P, Bruemmer D, Spencer C, Graf K, Grafe M, Law RE, Fleck E: TNFα inhibits insulin's antiapoptotic signaling in vascular smooth muscle cells. Biochem Biophys Res Commun 2001;287:662-670.
24. Federici M, Menghini R, Hribal ML, Lauro D, Sesti G, Lauro R: Insulin resistance is associated to increased matrix metalloproteinase-2 expression in vascular cells through a PI-3 kinase dependent mechanism (abstract). Diabetes 2001;50(suppl 2):A153.
25. Song J, Kim H, Rhee M, Chae I, Sohn D, Oh B, Lee M, Park Y, Choi Y, Lee Y: Effect of hypercholesterolemia on the sequential changes of apoptosis and proliferation after balloon injury to rabbit iliac artery. Atherosclerosis 2000;150:309-320.
26. Tashiro J, Takahashi K, Yokote K, Takahashi M, Inadera H, Kobayashi J, Kanzaki T, Murano S, Shinomiya M, Morisaki N, Saito Y: Administration of a small amount of lard enhances intimal thickening in the balloon catheter injury model without affecting serum lipids. Scand J Clin Lab Invest 1998;58:149-154.
27. Shoelson SE, Lee J, Yuan M: Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord 2003;27(suppl 3):S49-S52.
28. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH: Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 1991;40:1397-1403.
29. Tran TT, Gupta N, Goh T, Naigamwalla D, Chia MC, Koohestani N, Mehrotra S, McKeown-Eyssen G, Giacca A, Bruce WR: Direct measure of insulin sensitivity with the hyperinsulinemic-euglycemic clamp and surrogate measures of insulin sensitivity with the oral glucose tolerance test: correlations with aberrant crypt foci promotion in rats. Cancer Epidemiol Biomarkers Prev 2003;12:47-56.
30. Park SH, Marso SP, Zhou Z, Foroudi F, Topol EJ, Lincoff AM: Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus. Circulation 2001;104:815-819.
31. Capron L, Jarnet J, Kazandjian S, Housset E: Growth-promoting effects of diabetes and insulin on arteries. An in vivo study of rat aorta. Diabetes 1986;35:973-978.
32. Ridray S, Ktorza A, Picon L, Capron L: In vivo effect of insulin on the acute proliferative response of the rat aorta to injury. Arterioscler Thromb 1992;12:633-638.
33. Kubota T, Kubota N, Moroi M, Terauchi Y, Kobayashi T, Kamata K, Suzuki R, Tobe K, Namiki A, Aizawa S, Nagai R, Kadowaki T, Yamaguchi T: Lack of insulin receptor substrate-2 causes progressive neointima formation in response to vessel injury. Circulation 2003;107:3073-3080.
34. Indolfi C, Torella D, Cavuto L, Davalli AM, Coppola C, Esposito G, Carriero MV, Rapacciuolo A, Di Lorenzo E, Stabile E, Perrino C, Chieffo A, Pardo F, Chiariello M: Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. Circulation 2001;103:2980-2986.
35. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon MB: Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996;94:1247-1254.
36. Painter JA, Mintz GS, Wong SC, Popma JJ, Pichard AD, Kent KM, Satler LF, Leon MB: Serial intravascular ultrasound studies fail to show evidence of chronic Palmaz-Schatz stent recoil. Am J Cardiol 1995;75:398-400.